GSK plc bought WVE
December 11, 2025 · Form 4 insider transaction
GSK plc bought 1,470,000 shares of Wave Life Sciences, Inc. at $19.00 per share, a transaction worth $27.93M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,470,000
Price
$19.00
Total value
$27.93M
InsiderGSK plc
Role—
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after18,245,691
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").